PSG9 and preeclampsia: In conclusion, this study showed that the levels of PSG9 in the serum of patients with preeclampsia were significantly decreased, and further experimental studies indicated that the Ca2+/eNOS/NO signaling pathway was mediated by increased Orai1 and Orai2 expression levels to enhance NO release in HUVECs.